Literature DB >> 2087109

[Atropine poisoning by Mandragora autumnalis. A report of 15 cases].

M E Jiménez-Mejías1, M Montaño-Díaz, F López Pardo, E Campos Jiménez, M C Martín Cordero, M J Ayuso González.   

Abstract

Anticholinergic syndrome (AS) due to accidental poisoning is exceptional. Mandragora contains a high concentration of atropine, hiosciamine and scopolamine. We have evaluated 15 patients with AS due to poisoning by Mandragora autumnalis, distributed in two family groups. The latency period since the ingestion was 1-4 hours (Means = 2.7 +/- 0.9). The clinical features corresponded to an AS of variable severity. All patients had blurred vision and dryness of mouth, nine (60%) had difficult micturition, nine dizziness, nine headache, eight (53%) vomit, two difficult swallowing and two abdominal pain. There was no correlation between the latency period and the clinical severity. Blushing, areactive mydriasis and tachycardia were found in all, dry skin and mucosae in 14 (93%), hyperactivity/hallucination in 14 and agitation/delirium in nine (60%). One patient developed a florid psychotic episode. Prostigmine (2-6 mg) was administered to 11 patients and physostigmine (0.5-2 mg) to six. The time until a definite response was observed was variable (3-36 hours). The patients treated with physostigmine had a better reversal of the psychoneurological symptoms. Mandragora was identified intermingled with chard [correction of stalwort] (Beta vulgaris) and spinach (Spinacia oleracea) leaves, and atropine and hiosciamine were identified.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087109

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  A two cases clinical report of mandragora poisoning in primary care in Crete, Greece: two case report.

Authors:  Ioanna G Tsiligianni; Theodoros K Vasilopoulos; Polyvios K Papadokostakis; Georgia K Arseni; Astrinaki Eleni; Christos D Lionis
Journal:  Cases J       Date:  2009-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.